Director & Chief Scientific Officer
Director & Chief Scientific Officer at Edgewise Therapeutics, Inc., filing insider transactions between 2026-07-01 and 2026-08-12.
| SEC ↗ |
| 2026-07-01 | EWTX | Sale | 130.4K | $39.41 | $5.1M | SEC ↗ |
| 2026-07-01 | EWTX | Sale | 69.6K | $39.41 | $2.7M | SEC ↗ |